Answer
Teduglutide (Revestive) should preferably be avoided during breastfeeding as a precaution because its excretion into human milk is unknown and a risk to the breastfed newborn or infant cannot be excluded.
Sources for this answer
- Revestive 5 mg powder and solvent for solution for injectionTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 17Document updated
Sources checked